Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3490)
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,802
Price
$71.37
Total Value
$699.57K
Shares Held After
776,480
% of Holdings
1.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,398
Price
$70.29
Total Value
$98.26K
Shares Held After
786,282
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
100
Price
$67.85
Total Value
$6.78K
Shares Held After
787,680
% of Holdings
0.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
73,296
Price
$6.20
Total Value
$454.44K
Shares Held After
103,417
% of Holdings
41.5%
X4 Pharmaceuticals, Inc (XFOR)
KIRSKE DAVID — Chief Financial Officer
Shares
16,961
Price
$4.29
Total Value
$72.82K
Shares Held After
176,293
% of Holdings
8.8%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
3,322
Price
$26.71
Total Value
$88.73K
Shares Held After
466,375
% of Holdings
0.7%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
4,281
Price
$37.09
Total Value
$158.77K
Shares Held After
216,744
% of Holdings
1.9%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
14,219
Price
$36.64
Total Value
$520.98K
Shares Held After
221,025
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
Mesa Nilda — Director
Shares
258
Price
$581.93
Total Value
$150.14K
Shares Held After
5,028
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
56
Price
$583.44
Total Value
$32.67K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,464
Price
$582.80
Total Value
$853.22K
Shares Held After
40,569
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
982
Price
$581.62
Total Value
$571.15K
Shares Held After
42,033
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,706
Price
$580.62
Total Value
$990.53K
Shares Held After
43,015
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
492
Price
$579.67
Total Value
$285.20K
Shares Held After
44,721
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
778
Price
$578.46
Total Value
$450.04K
Shares Held After
45,213
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,062
Price
$577.44
Total Value
$613.24K
Shares Held After
45,991
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
767
Price
$576.23
Total Value
$441.97K
Shares Held After
47,053
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
753
Price
$575.47
Total Value
$433.33K
Shares Held After
47,820
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
401
Price
$573.70
Total Value
$230.05K
Shares Held After
48,573
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
293
Price
$573.12
Total Value
$167.92K
Shares Held After
48,974
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
106
Price
$571.71
Total Value
$60.60K
Shares Held After
49,267
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$570.31
Total Value
$228.13K
Shares Held After
49,373
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$568.83
Total Value
$136.52K
Shares Held After
49,773
% of Holdings
0.5%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
67,885
Price
$0.64
Total Value
$43.45K
Shares Held After
1,171,175
% of Holdings
5.5%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
75,000
Price
$100.12
Total Value
$7.51M
Shares Held After
523,478
% of Holdings
12.5%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$54.04
Total Value
$1.35M
Shares Held After
1,273,095
% of Holdings
1.9%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
6,719
Price
$0.64
Total Value
$4.30K
Shares Held After
406,282
% of Holdings
1.6%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
94,432
Price
$0.64
Total Value
$60.44K
Shares Held After
5,709,858
% of Holdings
1.6%
Lyell Immunopharma, Inc. (LYEL)
Hill Stephen J. — Chief Operating Officer
Shares
89
Price
$18.92
Total Value
$1.68K
Shares Held After
17,894
% of Holdings
0.5%
Lyell Immunopharma, Inc. (LYEL)
Lee Gary K. — Chief Scientific Officer
Shares
130
Price
$18.92
Total Value
$2.46K
Shares Held After
17,808
% of Holdings
0.7%
Lyell Immunopharma, Inc. (LYEL)
Seely Lynn — Director
Shares
388
Price
$18.91
Total Value
$7.34K
Shares Held After
73,878
% of Holdings
0.5%
Lyell Immunopharma, Inc. (LYEL)
Bulis Veronica Sanchez — VP, Corporate Controller
Shares
217
Price
$18.91
Total Value
$4.10K
Shares Held After
15,420
% of Holdings
1.4%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
6,476
Price
$5.76
Total Value
$37.30K
Shares Held After
188,448
% of Holdings
3.3%
Artiva Biotherapeutics, Inc. (ARTV)
GC Corp. — 10% Owner
Shares
347,222
Price
$11.52
Total Value
$4.00M
Shares Held After
1,607,734
% of Holdings
21.6%
Artiva Biotherapeutics, Inc. (ARTV)
GC Corp. — 10% Owner
Shares
1,085,069
Price
$11.52
Total Value
$12.50M
Shares Held After
4,391,969
% of Holdings
24.7%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
19,900
Price
$14.00
Total Value
$278.60K
Shares Held After
829,784
% of Holdings
2.4%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
25,000
Price
$14.00
Total Value
$350.00K
Shares Held After
809,884
% of Holdings
3.1%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
5,100
Price
$14.00
Total Value
$71.39K
Shares Held After
784,884
% of Holdings
0.6%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,171
Price
$29.71
Total Value
$64.50K
Shares Held After
69,792
% of Holdings
3.0%
Janux Therapeutics, Inc. (JANX)
Dobek Maria — Vice President, Accounting
Shares
2,038
Price
$14.17
Total Value
$28.88K
Shares Held After
32,270
% of Holdings
5.9%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's Title: EVP, Chief Medical Officer
Shares
222
Price
$21.05
Total Value
$4.67K
Shares Held After
120,244
% of Holdings
0.2%
Arcutis Biotherapeutics, Inc. (ARQT)
Vairavan Latha — SVP Chief Financial Officer
Shares
435
Price
$21.05
Total Value
$9.16K
Shares Held After
85,978
% of Holdings
0.5%
Rapport Therapeutics, Inc. (RAPP)
Third Rock Ventures V, L.P. — 10% Owner
Shares
133,618
Price
$40.24
Total Value
$5.38M
Shares Held After
6,299,097
% of Holdings
2.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
6,700
Price
$66.33
Total Value
$444.39K
Shares Held After
767,780
% of Holdings
0.9%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,575
Price
$65.46
Total Value
$234.01K
Shares Held After
774,480
% of Holdings
0.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,725
Price
$64.63
Total Value
$628.54K
Shares Held After
778,055
% of Holdings
1.2%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
22,177
Price
$6.75
Total Value
$149.69K
Shares Held After
176,713
% of Holdings
11.2%
Vericel Corp (VCEL)
Wotton Paul K — Director
Shares
7,500
Price
$32.64
Total Value
$244.80K
Shares Held After
18,802
% of Holdings
28.5%
Vericel Corp (VCEL)
Wotton Paul K — Director
Shares
2,500
Price
$33.05
Total Value
$82.62K
Shares Held After
26,302
% of Holdings
8.7%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
6,510,416
Price
$11.52
Total Value
$75.00M
Shares Held After
15,203,995
% of Holdings
42.8%
Showing 951–1000 of 3490 transactions (page 20 of 70)